Novo Nordisk has experienced a notable decline in its stock price, dropping by 12.08% over the past week. This downturn comes amid increased competition in the weight loss and dia ...

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

South Korea's financial watchdog ordered on Thursday Hanwha Aerospace to submit another revision to its share issue plan, ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

Discover why VKTX's deep selloff offers a compelling opportunity with improved safety margins, promising GLP-1 candidates, ...

Gluco Armor's Liquid Formula Emerges as a Natural, Science-Backed Solution for Blood Sugar Support, Offering a Functional ...

Mr Trump’s call for the Fed to lower interest rates came as the European Central Bank yesterday cut eurozone interest rates ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

A judge issued her order after Trump officials continually refused to retrieve Abrego Garcia, saying they defied a ...

Eli Lilly has followed Novo Nordisk in announcing a big investment in its manufacturing ... diabetes and obesity therapies – respectively Ozempic and Wegovy – Lilly has faced burgeoning ...